The researchers demonstrated the use of this technology, which they call “circulatronics,” to target brain inflammation, a ...
The Kanazawa team led by Katsuya Sakai, discovered that CHD1 uses a flexible region to form tiny liquid-like droplets, called condensates, that act as hubs for controlling the activity of crucial ...